Quantitative Investment Management’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-8,101
Closed -$224K 277
2021
Q3
$224K Buy
+8,101
New +$247K 0.02% 352
2020
Q2
Sell
-60,563
Closed -$626K 531
2020
Q1
$626K Buy
+60,563
New +$1.69M 0.07% 286
2019
Q1
Sell
-27,200
Closed -$1.62M 673
2018
Q4
$1.62M Buy
27,200
+22,400
+467% +$1.93M 0.08% 219
2018
Q3
$555K Sell
4,800
-6,800
-59% -$767K 0.02% 411
2018
Q2
$1.46M Sell
11,600
-21,300
-65% -$2.59M 0.03% 422
2018
Q1
$3.56M Buy
+32,900
New +$3.64M 0.06% 343
2017
Q1
Sell
-24,800
Closed -$2.98M 713
2016
Q4
$2.98M Buy
+24,800
New +$2.75M 0.07% 387
2016
Q3
Sell
-5,200
Closed -$644K 689
2016
Q2
$644K Sell
5,200
-4,600
-47% -$555K 0.03% 504
2016
Q1
$1.1M Buy
+9,800
New +$1.02M 0.05% 380
2013
Q4
Sell
-1,700
Closed -$287K 586
2013
Q3
$287K Sell
1,700
-100
-6% -$15.5K 0.03% 448
2013
Q2
$272K Buy
+1,800
New +$255K 0.05% 344

Other funds holding CLB

Quantitative Investment Management's CLB Position: Q4 2021 in Review

Quantitative Investment Management sold out of Core Laboratories (CLB) in Q4 2021, closing a stake of 8,101 shares — an estimated $224K sold.

Quantitative Investment Management first reported a position in CLB in Q2 2013 and held it in 11 quarters. The position peaked at $3.56M in Q1 2018. 173 funds tracked by Wall St. Rank hold CLB as of Q4 2021.

  • Quantitative Investment Management reported no remaining Core Laboratories position as of Q4 2021 after selling out during the quarter.
  • Quantitative Investment Management sold 8,101 Core Laboratories shares in Q4 2021, an estimated $224K.
  • Quantitative Investment Management first reported a position in Core Laboratories in Q2 2013 and held it in 11 quarters.
  • Quantitative Investment Management's Core Laboratories position peaked at $3.56M in Q1 2018.
  • 173 funds tracked by Wall St. Rank held Core Laboratories as of Q4 2021.

Based on Quantitative Investment Management's 13F filing for Q4 2021, filed 14 Feb 2022.